Gubra webinar: Preclinical drug discovery in NASH

Gubra webinar: Preclinical drug discovery in NASH. This webinar with Gubra scientist and NASH expert Henrik Björk Hansen will focus on strategies to improve clinical translatability of preclinical models of NASH.

Gubra Services

Liver (NASH)

Benefit from our extensive know-how in NASH and test your compound in our validated DIO NASH mouse models.

Learn more

Kidney

Check out our novel rodent models of diabetic nephropathy.

Learn more

3D Imaging

Use quantitative light-sheet fluoresence microscopy to validate pre-clinical endpoints.

Learn more

Obesity

Tap into our vast scientific experience with diet-induced obesity (DIO) models and other commercially available models.

Learn more

Heart (CVD)

Check out our novel rodent models of cardiovascular disease.

Learn more

Brain

Check out our capabilities in neurodegenerative diseases.

Learn more

Diabetes

Qualify and advance your assessment of novel compounds to treat type 2 diabetes and diabetic complications.

Learn more

Lung (IPF)

Check out our services within lung diseases.

Learn more

Gubra webinar: Preclinical drug discovery in NASH

Recent Posts

Recent Comments

Archives

Categories

Meta

Gubra Services